No abstract available
MeSH terms
-
Anticholesteremic Agents / administration & dosage*
-
Anticholesteremic Agents / adverse effects*
-
Cerebral Hemorrhage / chemically induced*
-
Cerebral Hemorrhage / complications
-
Cerebrovascular Disorders / complications
-
Clinical Trials as Topic
-
Coronary Disease / complications
-
Decision Support Techniques
-
Evidence-Based Medicine
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
-
Hypercholesterolemia / drug therapy*
-
Odds Ratio
-
Quality of Life
-
Risk Assessment
-
Treatment Outcome
Substances
-
Anticholesteremic Agents
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors